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Abstract
Background: Traditional medicine use has been reported is common among individuals with
moderate and advanced HIV disease. The aim of this cross-sectional study was to assess the use of
Traditional Complementary and Alternative Medicine (TCAM) for HIV patients prior to initiating
antiretroviral therapy in three public hospitals in KwaZulu-Natal, South Africa.
Methods: Using systematic sampling, 618 HIV-positive patients were selected from outpatient
departments from three hospitals and interviewed with a questionnaire.
Results: TCAM was commonly used for HIV in the past six months by study participants (317,
51.3%) and herbal therapies alone (183, 29.6%). The use of micronutrients (42.9%) was excluded
from TCAM since mostly vitamins were provided by the health facility. Herbal therapies were the
most expensive, costing on average 128 Rand (US$16) per patient per month. Most participants
(90%) indicated that their health care provider was not aware that they were taking herbal
therapies for HIV (90%). Herbal therapies were mainly used for pain relief (87.1%) and spiritual
practices or prayer for stress relief (77.6%). Multivariate logistic regression with use of herbs for
HIV as the dependent variable identified being on a disability grant and fewer clinic visits to be
associated with use of herbs, and TCAM use for HIV identified being on a disability grant, number
of HIV symptoms and family members not contributing to main source of household income to be
associated with TCAM use.
Conclusion: Traditional herbal therapies and TCAM are commonly used by HIV treatment naïve
outpatients of public health facilities in South Africa. Health care providers should routinely screen
patients on TCAM use when initiating ART and also during follow-up and monitoring keeping in
mind that these patients may not fully disclose other therapies.
Background
In November 2003, the South African Cabinet approved
The Operational Plan for Comprehensive HIV and AIDS
Care, Management and Treatment for South Africa [1]. In
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this plan the proposed range of care for patients encom-
passed a broad range of treatment options. South Africans
living with HIV/AIDS are now encouraged to make their
own informed choices about the types of treatment they
wish to seek including antiretrovirals (ART), exercise,
nutrition, as well as traditional and complementary med-
icines (TCAM).
Towards the end of the 1990s, the total number of tradi-
tional healers in South Africa was estimated to be around
350,000 [2] and an estimated 70 to 80% of South Africans
consult traditional healers [3,4]. The freedom of choice
for patients to select their treatment modality, the availa-
bility and easy access to traditional medicine, the cultural
beliefs and preponderance of TCAM use increase the like-
lihood that ARTs are used with other medicines in South
Africa. Studies outside of South Africa have found high
rates of TCAM utilization amongst people living with HIV
ranging from 15% to 79%, with some researchers suggest-
ing that people infected with HIV use TCAM at substan-
tially higher rates than people with other serious illnesses
[5-7].
Anecdotal evidence from South Africa suggests that a
number of ART patients resort to traditional medicine
after experiencing side effects from ART. Among such
patients, few data are available on the prevalence and pat-
terns of traditional and alternative therapy use. The South
African National ARV Treatment Guidelines [8] state that
patients must disclose any over-the-counter drugs and tra-
ditional medicines due to the possibility of contraindica-
tions and adverse drug interactions. However, previously
published research in the United States has found that up
to 70% of patients who use such therapies do not tell their
doctors [9]. Potential harmful interactions between some
TCAM and ARVs have been shown for garlic, St. John's
Wort [10], Hypoxis (African potato) and Sutherlandia
frutescens [11], as well as vitamins and cannabis [5]. It is
also important to note that many of the herbal medicines
used by several people have not been quantified nor ana-
lyzed for its active and inactive components. Langlois-
Klassen, Kipp, Jhangri and Rubaale [12] studied the use of
traditional herbal medicine by 137 AIDS patients in Kaba-
role District, western Uganda. Overall, 63.5% of AIDS
patients had used herbal medicine after HIV diagnosis for
any ailment. Babb et al. [13] studied individuals (n = 44)
with moderate or advanced HIV disease attending a work-
place clinic providing ART in South Africa, and found that
32% were using traditional medicines, most frequently
African potato (9/14) and Aloe vera (3/14), and Malangu
[14] found among HIV-infected patients on ART (n = 180)
in Pretoria, South Africa, that 4.4% used African tradi-
tional medicine and 3.3% complementary and alternative
medicines. Chopra [15] found that awareness of antiretro-
viral therapy in South Africa was generally poor. Antiret-
roviral drugs were not perceived as new, but one of many
alternative therapies for HIV and AIDS. Respondents had
more detailed knowledge of indications, effects and how
to access alternative treatments, which is bolstered by the
active promotion and legitimization of alternative treat-
ments.
Liu [16] systematically assessed the beneficial and harm-
ful effects of herbal medicines in people with HIV infec-
tion and AIDS. Based on a Cochrane review and updated
searches, the author identified the available evidence on
herbal medicines compared with placebo or antiretroviral
drugs in patients with HIV infection, HIV-related disease
or AIDS. There were ten randomised controlled trials,
involving 571 individuals with HIV infection or AIDS that
met the inclusion criteria. Some herbal medicines, such as
IGM-1 seem to be effective in symptom improvement, but
generally no significant effect on antiviral or immunity
enhancement among reviewed herbs was seen. These
findings suggest beneficial effects from some of the tested
herbs but results from larger studies are needed to support
this evidence in the future.
A patient's level of knowledge about HIV disease, a belief
that ART is effective and prolongs life, and a recognition
that poor adherence may result in viral resistance and
treatment failure all impact favourably upon a patient's
ability to adhere [17]. Beliefs about the medications
(including traditional) themselves also play a role in
adherence. Patients who report low confidence in the effi-
cacy of the medications and perceive minimal benefits
resulting from ART are less likely to be adherent [18]. Lack
of faith in the medications combined with a poor outlook
for the future, often leaves little motivation for adherence
to prescribed pharmacotherapy. So far, the impact of
TCAM on the quality of care and patient outcome is not
known in South Africa. This study will therefore look at
patient characteristics and beliefs in TCAM, patterns of use
and perceived benefits. It is estimated from other studies
[5-7] that at least 30% of patients on ART will use any
form of TCAM.
The aim of this cross-sectional study was to assess the use
of Traditional, Complementary and Alternative Medicine
(TCAM) for HIV patients prior to antiretroviral therapy in
three public hospitals in KwaZulu-Natal, South Africa.
Methods
Design
This is a cross-sectional study of all treatment naïve
patients recruited from all three public hospitals in
Uthukela health district in KwaZulu-Natal from October
2007 to February 2008. All ART-naïve patients who were
about to commence ART (18 years and above) and who
consecutively attended the HIV clinics during the recruit-
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ment period were eligible for this study. The Uthukela
Health District has a population of 553 671 and com-
prises five local authority areas. The District has one
regional and two district hospitals, one private hospital,
three primary health care facilities, 24 fixed clinics and 17
mobile clinics with 177 visiting points [19]. Initiation to
ART is done at the three public hospitals. Some patients
are referred to primary care clinics for ARV collection but
return to the hospital for six monthly visits.
Sampling procedure and recruitment
Systematic sampling was used by asking health care pro-
viders for referrals of ART-naïve patients (having a CD4
count below 200, eligible for ARV treatment but who had
not commenced ARV treatment yet). Physicians from the
three selected public clinics asked every consecutively vis-
iting ART-naïve patient meeting the inclusion criteria of
being 18 years or over (until at least 100 ART-naïve
patients were found per clinic) if they would like to com-
plete a confidential survey and interview concerning their
health and social situation. This would include informa-
tion from their medical records on details of their medical
condition, laboratory tests and treatment. It was made
clear to patients that their participation in this study was
voluntary and a decision not to participate would not
affect their medical care. If the potential participant indi-
cated an interest in participating, the health care provider
then referred them to an external HSRC research assistant.
Before the survey was administered, individuals were
given background information on the study. ART-naïve
patients were then asked to sign and complete a consent
form before the interview took place in a private area in or
outside the clinic. The interviews were conducted by four
trained external HSRC researchers (one or two per HIV
clinic) in interview administration of the semi-structure
interview schedule. Permission to access patient medical
records was sought from both the patient and the health
worker/manager. Questionnaires were anonymised, with
no personal identifying information recorded on them.
Recruitment took place over a period of four months, with
97.8% participation rate. Data were collected using an
interviewer-administered semi-structured questionnaire.
The questionnaire was translated into the major language
spoken in the study area (Zulu) and verified by a second
translator. Where inconsistencies were found, these were
corrected. Pre-testing of the questionnaire was completed
with five HIV-positive persons not involved in the study.
Ethical approval
The study protocol was approved by the Human Sciences
Research Council ethics committee, the KwaZulu-Natal
Department of Health, the Uthukela health district and
the three superintendents of the three study hospitals.
Outcome measures
Background information included socio-demographic
characteristics, clinical history and health-related charac-
teristics. Clinical data relating to date of HIV diagnosis,
HIV risk factors, current CD4 cell count, opportunistic
infections, HIV and non-HIV medications was obtained
from the medical chart [20].
The Revised Sign and Symptom Checklist for Persons with HIV 
Disease
The SSC-HIVrev is a 72-item checklist of HIV/AIDS-spe-
cific physical and psychological symptoms, scored using
the following scale: 0 = not checked (not present today),
1 = mild, 2 = moderate, 3= severe [21]. Analysis excluded
the eight gynaecological problems, only relevant to
women. Calculations included the total number of symp-
toms checked as present today (with a range of 0–64) and
the total symptom intensity is a weighting of symptoms
checked by the 1-to-3 rating of mild, moderate, or severe
[21]. Validity and reliability of the instrument have previ-
ously been reported for a U.S. sample [21] and various
African countries including South Africa [22]. Reliability
estimates were calculated using Cronbach's alpha, which
was .95 in this sample for the 64-item checklist. The total
HIV symptom frequency showed a significantly non-nor-
mal distribution [D(612) = 0.21, P < .001] (Kolmogorov-
Smirnow test).
Traditional, complementary and alternative medicine (TCAM) 
measure
Data were collected on prevalence, patterns and costs of
TCAM use in conjunction with conventional drugs. A ver-
bal explanation of TCAM was provided to each participant
as follows: Traditional, complementary and alternative
medicine has been defined broadly. It includes everything
from herbal medications such as St. John's wort, African
potato, cannabis to spiritual practices and prayer. It also
includes things like Traditional Chinese Medicines, acu-
puncture, acupressure, chiropractic care, and massage
therapy. Techniques such as meditation, visualization,
and therapeutic touch would also be included. In addi-
tion, micronutrients (vitamins, minerals, and multivita-
mins) are included. Specific questions were asked about
18 different categories of TCAM, as follows: 1) Herbal
therapies (e.g., Ginseng, Echinacea or St. John's Wort,
Hypoxis plant (African potato); 2) Homeopathic therapies;
3) Traditional Chinese Medicine (including acupuncture,
acupressure or traditional Chinese practitioners); 4) Sup-
plements, nutraceuticals or Natural Health Products (e.g.,
N-acetyl-cysteine [NAC], melatonin, whey proteins, chon-
droitin); 5) Aromatherapy oils; 6) Chiropractic care; 7)
Massage; 8) Naturopathy; 9) Reflexology; 10) Hypnosis;
11) Faith healing methods; 12) Imagery or visualization
techniques; 13) Meditation; 14) Spiritual practices or
prayer; 15) Therapeutic touch; 16) Micronutrients (vita-
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mins, etc.); 17) Cannabis; 18) Exercise [23-25]. For each
agent reported, patients also provided the specific name of
the remedy, costs and reasons for use and physician
awareness of use [26].
HIV knowledge and patient-provider variables
Participants' HIV-related knowledge and orientation
towards treatment information were assessed with two
indicators. Self-assessed knowledge about HIV/AIDS was
measured with a single item, "How well-informed do you
rate yourself to be about HIV disease and treatment rela-
tive to most people who are HIV positive?" Response
options were 1 = much better informed than most to 5 =
much less informed than most. Responses indicating that
they perceived themselves to be "much better informed
than most" and "somewhat better informed than most"
were categorized as better informed (vs. those who viewed
themselves as being "about as well informed," "somewhat
less informed", or "much less informed") [6].
The desired level of information involvement was
assessed with two items, e.g. "I want to take an active role
in the medical management of my HIV infection and its
complications." Response options were 1 = strongly agree
to 4 strongly disagree. These items were combined into a
4-point scale in which higher scores indicate a stronger
desire for information [6]. Cronbach alpha for this infor-
mation desire index was .77 for this sample.
Participants' degree of trust in medical providers was
measured with two items, e.g. "How much do you trust
your doctor or clinic to offer you high-quality medical
care?" Response options were from 1 = completely to 5 =
not at all. Responses to these questions were reversed,
combined, and placed on a scale ranging from 0 to 100,
in which higher scores indicate higher trust [6]. Cronbach
alpha for this trust in medical providers' index was .88 for
this sample.
Desired level of decision involvement reflected the
extent to which participants wanted to be involved in
medical decision making, e.g., "It is better to trust a doctor
or a nurse in charge of a medical procedure than to ques-
tion what they are doing". Response options were 1 =
strongly agree to 4 strongly disagree. These items were
combined into a 4-point scale in which higher scores indi-
cate a stronger disagreement (i.e., greater desire for
involvement in decisions about medical care) [6]. Cron-
bach alpha for this desire for involvement in decisions
index was .72 for this sample.
The experience of discrimination in the health care sys-
tem was assessed with 3 items, e.g. "Has anyone in the
health care system ever exhibited hostility or a lack of
respect toward you?" Response options were "yes" or
"no". If the participant answered "yes" to any of the three
items, he or she was coded has having experienced dis-
crimination [6]. Cronbach alpha for this health care pro-
vider discrimination index was .77 for this sample.
Internalized AIDS stigma
Items were adapted to assess internalized AIDS stigmas
from a scale developed to measure AIDS related stigma
beliefs in general South African populations. We selected
four items from the AIDS-Related Stigma Scale [27] and
reframed the wording to represent negative self-percep-
tions and self-abasement in relation to being a person liv-
ing with HIV/AIDS. The items focused on self-blame (e.g.,
"I sometimes feel worthless because I am HIV positive.")
and concealment of HIV status from others (e.g., "I hide
my HIV status from others."). In this study, we examined
responses to each of the four internalized stigma items as
individual indicators of internalized AIDS stigma and we
computed a scale by summing all items endorsed in the
direction of greater internalized stigma. Items were
responded to from 1 = strongly agree to 4 = strongly disa-
gree. Strongly agree and agree were converted to "1" and
strongly disagree and disagree to "0"; scale scores repre-
sent the sum total of endorsed items, range 0–4. Cron-
bach alpha for this stigma index was .82 for this sample.
Health Beliefs
Four health beliefs were drawn from the Health Belief
Model (HBM) [28,29] and the revised HBM as described
by Ronis [30]. All beliefs are measured on a 5-point agree-
ment scale. Perceived benefits is a 2-item scale reflecting
what patients perceive they would derive from their treat-
ment adherence behaviours (e.g. prolonging life and
decreasing chance of getting worse) to TCAM respectively
(Cronbach alpha = .58). Perceived barriers is a 4-item scale
reflecting what patients perceive they would have to over-
come to adhere to TCAM. Perceived barriers were explored
as non-monetary (e.g. stress of treatment, side effects of
drugs, interrupted social activities) and monetary (e.g.
expenditures on drugs, TCAM) (Cronbach alpha = .80).
Perceived severity was the perceived seriousness of the dis-
ease and is measured in comparison to other illnesses (4
items) (Cronbach alpha = .78). [31].
Statistical analysis
Prevalence data as well as predictors of use were evaluated
for herb use and TCAM use. For subsequent analyses, par-
ticipants were categorized as herb or TCAM users or non-
users, where users are those patients reporting the use of
one or more herb or TCAM substances, depending on the
specific analysis being conducted. Variables were
inspected for skewness and those that domonstrated sig-
nificant divergence from normality were transformed
using Log10 [X+1] for regression analyses. Demographics,
non-prescription medication use, disease characteristics
BMC Public Health 2008, 8:255 http://www.biomedcentral.com/1471-2458/8/255
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(including CD4 count) were assessed in relation to TCAM
use/nonuse through bivariate analyses. Estimated rates of
TCAM use was calculated and bivariate associations
between the independent variables and any use of TCAM
for HIV in the past six months were investigated. Multivar-
iate logistic regression was used to estimate the influence
of each independent variable on the odds of using herbs
and TCAM; included in the model were all variables sig-
nificant at P < .05 in bivariate analysis. Collinearity diag-
nostics was conducted and all explanatory variables
(socio-demographic and health variable factors) had tol-
erance values of .8 and more indicating no multicollinear-
ity. The 95% confidence intervals for odds ratios and p
values obtained by logistic regression were obtained using
SPSS software, version 14.0 (Chicago, IL, United States).
In multivariate regressions, adjustment was made for the
hospital site, to account for TCAM variations and demo-
graphic differences across sites.
Results
Demographics
The sample included 618 Black African (almost all Zulu)
HIV-positive patients (29.1% male and 70.9% female)
prior to ART initiation, with an age range of 18 to 67 years
(Median = 34.00 years; interquartile range = 12). Almost
three-quarters of the sample were never married; only a
quarter had completed secondary or post-secondary edu-
cation and the largest proportion of patients (27%)
belonged to the Zion Christian Church. The sample are
further characterized by residing in rural areas (63.2%)
and high unemployment (63%) (see Table 1).
Health information
The majority (75.2%) of patients had received their HIV
diagnosis within the last year and 93.9% of participants
had a CD4 count below 200 cells/uL (v. Table 2), the cri-
teria to be put on ART in the public health sector in South
Africa. The participants reported that on the day of the
interview, they were experiencing a median of 5.0 symp-
toms (interquartile range = 12.0) out of a possible 64. The
top ten reported symptoms included concern over weight
loss, dry mouth, headaches, memory loss, weakness,
thirst, painful joints, chills (feeling very cold), chest pain
and lack of appetite. Most of the participants (82.9%) felt
that they were better informed than most about HIV dis-
ease and HIV treatment-related knowledge. Desired infor-
mation involvement (56.7%) and degree of trust in the
medical provider (62.1%) were both high, with medium
levels of decision involvement (49.9%). Only a few
(2.8%) reported to have experienced discrimination from
the health care systems (2.8%) (v. Table 2).
More than half of the participants (56.9%) had visited a
clinic three times or more in the past six months and
27.4% had been hospitalized. Very few respondents had
home visits (2%), participated in a support group (1%) or
had seen someone for counselling/support (6.5%).
TCAM was commonly used for HIV by study participants
(317, 51.3%) and herbal therapies alone (183, 29.6%).
The use of micronutrients (42.9%) was excluded from
TCAM since mostly vitamins were provided by the health
facility. Table 3 provides information about participants'
use of major types of TCAM, the length of usage, costs in
Rand per month and health care provider awareness
about TCAM use. The range of using TCAM types ranged
from 24 to 7 weeks (excluding cannabis, which was 38
weeks), with herbal therapies on average 12 weeks, faith
healing 10 weeks and micronutrients (vitamins, etc.) 16.5
weeks. Herbal therapies were the most expensive, with
one average 128 Rand (range 0–1000) per month, fol-
lowed by cannabis (37 Rand per month), faith healing
methods (24.4 Rand per month) and micronutrients 7.2
Rand per months (1 US$ = 7.60 Rand). Most participants
(90%) indicated that their health care provider was not
aware that they were taking herbal therapies for HIV
(90%) or faith healing methods for HIV (81.6%), while
most health care providers were aware that they were tak-
ing micronutrients (85.3%). TCAM use in females was
particularly related to religious and spiritual practices.
Women (42%) in this sample were much more likely to
belong to charismatic churches than men (21%) and used
faith healing methods (40% for women and 20% for men
respectively) and spiritual practices or prayer (15% vs.
7%) more often than men (p < .001) (see Table 3).
For each TCAM type participants were asked the reasons
for its use. Herbal therapies were mainly used for pain
relief (87.1%), immune supplementation (52.7%) and
stress relief (50.9%); cannabis for stress relief (85.7%);
spiritual practices or prayer for stress relief (77.6%), to
improve overall wellbeing (74.7%) and pain relief
(64.5%); faith healing methods for stress relief (80.4%);
exercise to improve overall wellbeing (76.9%); micronu-
trients (vitamins, etc.) for pain relief (94%) and immune
supplementation (81.3%) and over-the-counter drugs for
pain relief (87.9%). Twenty-five (4.1%) of the partici-
pants believed that they could treat HIV solely with
TCAM.
Bivariate analyses indicate that sex, age, educational level,
having health insurance, CD4 count levels, time since HIV
diagnosis and number of HIV symptoms were not associ-
ated with the use of herbs for HIV or HIV-related symp-
toms (v. Table 4). Age, having health insurance and time
since HIV diagnosis were also not associated with TCAM
use. Conversely, rural residence of patients, having no reli-
gious affiliation, not having money to meet needs, no
income (other than social grant), family members not
contributing to main source of household income, being
BMC Public Health 2008, 8:255 http://www.biomedcentral.com/1471-2458/8/255
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Table 1: Baseline characteristics
Variable N = 618 %
Sex
Male 180 29.1
Female 438 70.9
Age in years
18–29 167 27.0
30–39 269 43.5
40–49 121 19.6
50 and above 61 9.9
Marital status
Never married 433 71.0
Currently married 73 12.0
Cohabitating 68 11.1
Divorced/separated 14 2.3
Widowed 22 3.6
Highest education
None 42 6.8
Primary 447 72.7
Secondary 122 19.8
Post-secondary 4 .7
Ethnicity
Zulu 612 99.0
Other 6 1.0
Religious affiliation
African/traditional 58 9.4
Christian (Protestant churches) 88 14.2
Christian (Catholic) 40 6.5
Apostolic 57 9.2
Zion Christian Church 167 27.0
Other 102 16.5
No religion 106 17.2
Residence
Rural village 285 46.3
Informal settlements (slums) 30 4.9
Urban/metropolitan areas 47 7.6
Township 150 24.4
Farm 104 16.9
Employment situation
Housewife, home maker 86 14.1
Unemployed 383 63.0
Employed 117 19.2
Pensioner, student, disabled 22 3.6
Main source of household income
Formal salary 182 29.4
Contribution by adult members 115 18.6
Government grant 138 22.3
Grants/donations by private welfare organizations 87 14.1
No income (other than social grant) 45 7.3
Other 51 8.3
BMC Public Health 2008, 8:255 http://www.biomedcentral.com/1471-2458/8/255
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on a disability grant (for chronic illness including AIDS)
and fewer clinic visits were associated with the use of
herbs for HIV or HIV-related symptoms. Female sex, sec-
ondary/postsecondary education, rural residence of
patient, belonging to a charismatic church, not having
money to meet needs, family members not contributing
to main source of household income, having no income
(other than social grant), being on a disability grant (for
chronic illness including AIDS), fewer clinic visits in the
past six months and more frequent HIV symptoms were
associated with TCAM use. The use of over-the-counter
drugs was significantly associated with herb and TCAM
use (OR = 9.22, 5.14–16.53, P = .000 and OR= 38.33,
9.31–158.53, P = .000).
Multivariate logistic regression with use of herbs for HIV
as the dependent variable confirmed results from the uni-
variate analysis for being on a disability grant and fewer
clinic visits continued to be significantly associated with
use of herbs (v. Table 4). The association between not
enough money to meet needs, less income, religious affil-
iation and rural residence of the patient were no longer
significant in the multivariate model. Multivariate logistic
regression with TCAM use for HIV as the dependent vari-
able confirmed results from the univariate analysis,
namely that being on a disability grant, more frequent
HIV symptoms, and family members not contributing to
the main source of household income continued to be sig-
nificantly associated with use of TCAM. The association
between fewer clinic visits, CD4 count levels, not enough
money to meet needs, rural residence of patient, sex, edu-
cational level and religious affiliation were no longer sig-
nificant in the multivariate model (see Table 4).
Using a five-point scale (with 5 indicating very satisfied)
patient ratings of their health status were significantly dif-
ferent between users (median = 4.00, interquartile range =
1; mean rank = 318.77) and non-users (median = 4.00,
interquartile range = 1; mean rank = 292.59) of TCAM
(Mann-Whitney U test: Z = -1.985, P = 0.47), but users of
Table 2: Health characteristics
Variable N = 618 %
Time since HIV diagnosis
≤ 1 year (2007/8) 454 75.2
1–2 years (2006) 61 10.1
> 2–3 years (2005) 30 5.0
> 3 years (2004–1995) 59 9.8
CD4 count (cells/uL)
1–49 135 22.7
50–99 145 24.4
100–149 128 21.5
150–199 150 25.3
200 + 36 6.1
Number of HIV symptoms (range 0–55) Median = 5.00 Interquartile range = 12.00
HIV disease & HIV treatment related knowledge (better informed than most) 509 82.9
Information involvement score
4.0 345 56.7
3.0–3.9 255 41.9
< 3.0 9 1.5
Degree of trust in medical provider score
100 380 62.1
75–99 207 33.8
0–74 25 4.1
Discrimination by health care provider 17 2.8
Decision involvement score
4.0 281 46.8
3.0–3.9 300 49.9
< 3.0 20 3.3
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herbs (median = 4.00, interquartile range = 1; mean rank
= 265.27) were significantly less satisfied with their health
than non-users of herbs (median = 4.00, interquartile
range = 2; mean rank = 322.22) (Mann-Whitney U test: Z
= -3.897, P = .000). The majority of both TCAM and herb
users and nonusers reported overall health as satisfied or
very satisfied (median score for users and non-users = 4).
Self-rated HIV disease and treatment knowledge adjusted
for educational level did not differ between herb and non-
herb users (OR = 0.99, 0.84–1.18, P = .95), while TCAM
users adjusted for educational level had significantly
higher HIV disease and treatment knowledge than TCAM
non-users (OR = 1.49, 1.25–1.78, P = .000).
In univariate analysis TCAM users scored significantly
lower on information involvement, degree of trust in the
medical provider and decision involvement than non
TCAM users (OR = 0.39, 0.26–0.56, P = .000; OR = 0.96,
0.95–0.98, P = .000; and OR = 0.38, 0.27–0.56, P = .000,
respectively), and in multivariate logistic regression only
lower decision involvement (OR = 0.57, 0.35–0.93, P =
.024) was associated with TCAM use.
Internalized AIDS stigma (range 1 to 4, 4 being the high-
est) was with median 3.00 (interquartile range = 1.00)
high. Lower internalized AIDS stigma was associated with
higher use of herbs (Z = -2.151, P = .031) and TCAM (Z =
-2.692, P = .007).
Health beliefs
Perceived benefits from TCAM was generally rated average
(Median = 2.50), and perceived barriers to TCAM (Median
= 3.00), and perceived severity of HIV (Median = 2.75)
high. (v. Table 5). Perceived barriers of TCAM use were
positively associated with TCAM use (Mann-Whitney U
test Z = -4.36, P = .000) while perceived benefits of TCAM
use (Z = -1.26, P = .21) and perceived severity of HIV dis-
ease (Z = -1.02, P = .31) were not associated with TCAM
use (see Table 5).
Discussion
Amongst 618 HIV treatment naïve patients from three
public hospitals in KwaZulu-Natal, TCAM was commonly
used for HIV in the past six months by study participants
(317, 51.3%) and herbal therapies alone (183, 29.6%).
The use of micronutrients (42.9%) was excluded from
TCAM since mostly vitamins were provided by the health
facility. This finding compares with other studies in Africa
and elsewhere. Langlois-Klassen et al. [12] found that the
majority of AIDS out-patients (N = 87, 63.5%) in western
Uganda were using traditional herbal medicine after HIV
diagnosis. This seems to be for any type of health prob-
lem, while our study investigated TCAM specifically for
Table 3: Use of TCAM (Traditional, complementary and alternative medicine) for HIV in the past six months (N = 618)
Use duration in weeks Cost in Rand/month Health care provider aware of 
use
n % M (SD) [range] M (SD) [range] n (%)
Total TCAM usea 317 51.3
1. Herbal therapies 183 29.6
1a. Herbal therapies 177 28.6 12.1 (9.0) [1–48] 128 (189) [0–1000] 18 (10.2)
1b. Cannabis 23 3.7 38.1 (37.5) [1–140] 37.3 (90.5) [0–400] 0
2. Religious healing 217 35.1
2a. Spiritual practices or prayer 208 33.2 18.3 (10.1) [1–48] 0 69 (39.2)
2b. Faith healing methods 78 12.4 9.7 (9.5) [1–42] 24.4 (109.0) [0–500] 9 (18.4)
3. Physical/body-mind therapy 47 7.5
3a. Exercise 29 4.6 12.6 (9.2) [1–28] 1.1 (3.3) [0–10] 8 (30.8)
3b. Massage 7 1.1 8.5 (10.9) [1–24] 10.0 (17.3) [0–30]
3c. Therapeutic touch 6 1.0 10.0 (9.6) [2–24] 0
3d. Meditation 5 0.8 24.0 [24-24] 0
4. Micronutrients 
(vitamins, minerals & multivitamin)
266 42.9 16.5 (9.3) [1–48] 7.2 (69.1) [0–800] 227 (85.3)
5. Over-the-counter drugs 77 12.5 5.1 (6.4) [1–21] 4.3 (13.2) [1–99] 7 (10.9)
a The use of micronutrients (42.9%) was excluded from TCAM since mostly vitamins were provided by the health facility
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Table 4: Odds ratios (ORs) and 95% confidence intervals (95% CIs) for herb use and TCAM use, univariate and multivariate analyses
Univariate analyses Multivariate analyses
Herb use TCAM use Herb use TCAM use
% OR (95% CI) P % OR (95% CI) P OR (95% CI) P OR (95% CI) P
Sex
Male (n = 180) 29.9 1.00 (reference) 42.9 1.00 (ref) 1.00 (ref)
Female (n = 438) 29.3 0.97 (0.66–1.42) .86 54.8 1.61 (1.13–2.30) .008 1.23 (0.63–2.61) .501
Age in years 1.00 (0.98–1.02) .89 0.99 (0.97–1.01) .25
Educational level
None (n = 42) 21.4 1.00 (ref) 45.2 1.00 (ref) 1.00 (ref)
Primary (n = 446) 28.9 1.49 (0.69–3.21) .305 48.4 1.14 (0.60–2.15) .692 0.99 (0.33–3.03) .996
Secondary/postsecondary 
(n = 126)
35.7 2.04 (0.90–4.64) .090 65.1 2.26 (1.11–4.59) .025 2.62 (0.77–8.87) .122
Residence
Urban (n = 227) 16.3 1.00 (ref) 40.5 1.00 (ref) 1.00 (ref) 1.00 (ref)
Rural (n = 388) 37.6 3.00 (2.06–4.66) .000 58.0 2.03 (1.45–2.83) .000 1.53 (0.84–2.79) .1.64 1.56 (0.84–1.99) .157
Religion
Christian (main stream) 
(n = 128)
21.1 1.00 (ref) 41.4 1.00 (ref) 1.00 (ref) 1.00 (ref)
Charismatic (n = 230) 27.0 1.38 (0.83–2.31) .220 53.5 1.63 (1.05–2.52) .029 0.88 (0.44–1.79) .726 1.23 (0.62–2.46) .597
No religion (n = 106) 42.5 2.76 (1.56–4.90) .001 52.8 1.59 (0.94–2.66) .082 1.27 (0.53–3.03) .588 1.15 (0.55–1.88) .224
African/traditional 
(n = 58)
29.3 1.55 (0.77–3.15) .224 32.8 0.69 (0.36–1.32) .263 1.30 (0.50–3.25) .594 0.35 (0.12–1.07) .66
Enough money to meet 
needs
Not at all (n = 294) 43.0 1.00 (ref) 63.2 1.00 (ref) 1.00 (ref) 1.00 (ref)
A little (= 170) 19.4 0.32 (0.21–0.50) .000 48.2 0.54 (0.37–0.80) .002 0.53 (0.26–1.09) .083 1.37 (0.76–2.45) .293
Moderately/mostly/
completely (n = 140)
14.0 0.22 (0.13–0.36) .000 30.7 0.26 (0.17–0.39) .000 0.69 (0.29–1.65) .404 1.14 (0.60–2.17) .686
Main source of household 
income
Formal salary (n = 182) 29.1 1.00 (ref) 58.2 1.00 (ref) 1.00 (ref) 1.00 (ref)
Contribution by family 
members (n = 115)
15.7 0.45 (0.25–0.82) .009 25.2 0.24 (0.15–0.40) .000 0.61 (0.29–1.31) .207 0.32 (0.14–0.70) .005
Government grant 
(n = 138)
39.9 1.61 (1.01–2.57) .045 58.0 0.99 (0.63–1.55) .961 1.62 (0.82–3.10) .164 0.89 (0.43–1.47) .745
Grants/donations by 
private welfare (n = 87)
21.8 0.68 (0.37–1.24) .208 44.8 0.58 (0.35–0.98) .040 0.50 (0.20–1.24) .135 0.77 (0.19–0.84) .578
No income (other than 
social grant) (n = 44)
54.5 2.92 (1.49–5.37) .002 88.6 5.59 (2.11–14.85) .001 0.24 (0.02–3.72) .309 1.45 (0.21–9.88) .706
Being on a disability 
grant (chronic illness 
including AIDS) (n = 128)
No 16.1 1.00 (ref) 27.6 1.00 (ref) 1.00 (ref) 1.00 (ref)
Yes 32.0 2.46 (1.54–3.93) .000 72.7 6.98 (4.43–10.99) .000 3.42 (1.65–7.11) .001 7.85 (3.38–18.25) .000
Having a health 
insurance
Yes (n = 64) 28.1 1.00 (ref) 40.6 1.00 (ref)
No (n = 548) 30.0 1.09 (0.61–1.94) .76 52.8 1.64 (0.97–2.77) .066
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HIV treatment. Roughly half (49%) of the HIV partici-
pants in an Australian study had used TCAMs to manage
their HIV/AIDS [32]. The use of micronutrients (43%) in
this study was similar among HIV positive patients in
Thailand (51%) [7] but lower than HIV out-patients in
Canada (89%) [23].
Most participants in this study indicated that their health
care provider was not aware that they were taking herbal
therapies (90%) and faith healing methods for HIV
(81.6%). Furler et al. [23] found among Canadian HIV
outpatients that more than half (53%) did not report any
TCAM use to their treating physician. Given the potential
for adverse reactions and drug interactions related to
TCAM use, health care providers' awareness of TCAM use
is crucial to optimize patient care [23]. Health care provid-
ers should be informed about this to include inquiring
about herbal and TCAM use for both HIV-related illnesses
and other comorbid conditions as part of their history tak-
ing and clinical assessments [12].
Despite an apparent reluctance of the South African
patients to inform the treating health care provider of
TCAM use, the vast majority of patients in our study
reported a high degree of satisfaction with the conven-
tional medical treatment they were receiving. However,
TCAM users as well as herb users alone were significantly
less satisfied with their health care provider than TCAM as
well as herb non-users, which is conform to a study by
Sutherland and Verhoef [33]. This study found that TCAM
users scored significantly lower on decision involvement
than non TCAM users. The opposite was found among
American TCAM users [6].
CD4 count 1.00 (0.99–1.00) .39 1.00 (1.00–1.01) .049 1.57 (0.70–3.55) .275
Time since HIV diagnosis
≤ 1 year (n = 460) 28.9 1.00 (ref) 50.1 1.00 (ref)
> 1 and more years 
(n = 151)
28.7 1.01 (0.67–1.52) .95 52.0 0.93 (0.64–1.34) .69
Number of clinic visits in 
past 6 months
Never or once (n = 116) 50.9 1.00 (ref) 69.0 1.00 (ref) 1.00 (ref) 1.00 (ref)
Twice (n = 147) 21.1 0.26 (0.15–0.44) .000 32.0 0.21 .000 0.64 (0.26–1.61) .159 0.66 (0.23–1.89) .443.
Trice or more (n = 348) 25.6 0.51 (0.33–0.80) .000 53.2 0.51 .003 0.51 (0.23–1.12) .047 0.97 (0.39–2.42) 951
Number of HIV 
symptoms
1.00 (0.99–1.02) .64 1.03 (1.01–1.05) .001 2.26 (1.28–3.99) .005
Nagelkerke R Square .19 .44
Table 4: Odds ratios (ORs) and 95% confidence intervals (95% CIs) for herb use and TCAM use, univariate and multivariate analyses 
(Continued)
Table 5: Health beliefs towards TCAM HIV treatment
Domain Variable Median Interquartile range
Perceived benefits 
(Median = 2.50, Interquartile range = 1.00)
Adherence to TCAM HIV treatment can prolong my life 4.00a 2
Adherence to TCAM HIV treatment can decrease the 
chances of getting worse
4.00 1
Perceived barriers 
(Median = 3.00, Interquartile range = 1.50)
Dealing with TCAM HIV treatment side effects is stressful 3.00 2
TCAM HIV treatment cause annoying side effects 3.00 2
Taking TCAM HIV treatment interferes a great deal with 
normal activities
3.00 2
Taking TCAM HIV treatment costs a lot 2.00 3
Perceived severity 
(Median = 2.75, Interquartile range = 0.75)
My current infection with HIV will lead to serious long-term 
health problems (reverse scored)
3.00 2
I will become very sick as a result of my infection with HIV 
(reverse scored)
3.00 1
Compared to other illnesses, HIV infection is not serious 3.00 2
Whenever I get sick it seems to be serious (reverse scored) 2.00 2
a rated from 1 to 5, 5 being the highest
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Herbal therapies were mainly used for pain relief,
immune supplementation and stress relief, spiritual prac-
tices or prayer for stress relief, to improve overall wellbe-
ing and pain relief, faith healing methods for stress relief,
exercise to improve overall wellbeing, and micronutrients
(vitamins, etc.) for pain relief and immune supplementa-
tion. Only a few (4.1%) of the participants believed that
they could treat HIV solely with TCAM. Furler et al. [23]
found among HIV-infected outpatients in Ontario, Can-
ada, that the most common patient-cited reason for
TCAM use was general wellbeing, followed by relaxation,
pain, stress, spiritualism and healing; 9% believed that it
was possible to treat HIV solely with the use of TCAM.
Dhalla et al. [5] found among HIV patients in British
Columbia that major reasons for CAM use were to
improve energy level, to supplement dietary intake and to
enhance immune response, and in a U.S. sample, Kirksey
et al. [24] found that the most common treated conditions
by TCAM were anxiety/fear, depression, pain and neurop-
athy. Among ethnically diverse patients in the U.S. Cole-
man et al. [34] found that prayer was used as a
complementary health strategy for HIV-related anxiety,
depression, fatigue, and nausea. In this South African
study, cannabis was mainly used for stress relief (85.7%)
and to a lesser extent for recreational purposes (relaxa-
tion) (23.5%) and pain relief (17.6%). Cannabis in South
Africa is grown especially in the rural areas illegally and
sold in different quantities depending on the users needs
[35]. In rural South Africa, cannabis is also grown for per-
sonal usage. Fogarty et al. [36] also found that 44.3% of an
Australian HIV patient sample reported mixed use of mar-
ijuana for therapeutic and recreational purposes. Further
research might consider possible interactions between
cannabinoids and antiretroviral treatments, potential use
of oral THC and the difficulties faced by clinicians and
PLWHA in discussing cannabis use in the current legal
context.
Higher HIV symptom frequency was associated with more
frequent TCAM use but not herbal therapy use. Reports
from developed countries indicate an association between
increased use of complementary therapies and higher
degrees of suffering [e.g. [37]]. Langlois-Klassen et al. [12]
also found that the majority of the AIDS patients in their
study in western Uganda used traditional herbal medicine
for fever and pain.
The use of over-the-counter drugs was found to be highly
associated with herb and TCAM use in this study, which
conforms to other studies [e.g. [23]].
This study found female HIV patients were also engaged
more frequently in TCAM use than male patients, while
herbal therapies were used to similar extents by both male
and female HIV patients. Female patients, particularly
those who belonged to charismatic churches, used greater
amounts of faith healing and spiritual care practices than
males in this sample. In Mozambique, Pfeiffer [38] found
that poorer women with sick children preferred to use the
prophets in the African Independent Churches (AIC) or
charismatic churches instead of traditional healers as they
didn't have to pay at the prophets. The popularity of the
AICs in this context has been attributed to growing social
inequalities which have resulted in heightened social ten-
sions, violence and individual competition for jobs and
social improvement, declining social cohesion and
increased spousal conflict in poorer families [39]. With
traditional healers catering mostly for men wishing to
improve their luck and job prospects, many women have
turned to the AICs. As well as finding traditional healers
too expensive, many women worry that they themselves
may be accused of witchcraft. The AICs have offered these
women a new healing process which encourages mutual
aid and support and avoidance of conflict. Other studies
[e.g. [12]] found that female patients generally more fre-
quently utilize traditional health medicine or TCAM
[23,39] than male patients.
Herbal therapies were the most expensive, costing on
average 128 Rand per patient per month. Other studies in
South Africa even found higher costs of traditional herbal
HIV medicines, 27–45 British pounds as reported by
patients [13]. The reported costs for TCAM, at up to 100
US$ per month, represent a substantial proportion of the
income of an average patient attending the clinic. This
study found that the use of herbs for HIV was associated
with being on a disability grant and fewer clinic visits of
the patient. TCAM use for HIV was associated with being
on a disability grant, "family members do not contribute
to main source of household income", and number of
HIV symptoms. Furler et al. [23] also found among HIV
out-patients in Canada that TCAM users were more often
receiving disability benefits than non TCAM users. The
high costs of TCAM meant that users were not necessarily
able to use them as much as they might have liked [cf also
[32]]. One of the main types of TCAM use was that of
prayer (no cost) and faith healing methods, which on
average was lower in cost than herbal remedies. Studies
amongst Black African HIV-positive patients in the UK
have found that religion, as well as providing a spiritual
coping mechanism for dealing with difficult life events,
also provided practical support as a family might [40-42].
Studies have also found however that religious and spirit-
ual beliefs may conflict with mainstream HIV treatment
and care, particularly if patients believe that prayer alone
may cure them [41,43].
Public health services including antiretroviral treatment
are free in South Africa for primary health care and for
hospital care a small user fee is collected. Despite rela-
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tively good access to conventional health care services,
limited affordability of traditional health care including
complementary care, and the current incurability of HIV/
AIDS appear to restrict the use of TCAM. Likewise, limited
affordability to access public health services may explain
why AIDS patients in this study used TCAM. Patients must
visit a treatment clinic at least six times in the year in
which they start ART. The average cost per visit is R120,
plus travel and waiting time [44].
In our analysis, we found no associations between TCAM
and or herb use and years since HIV diagnosis and CD4
count. Most patients in this sample had a low CD4 cell
count (below 200) and most had been diagnosed very
recently with HIV. Other previous studies in HIV also
failed to find a significant difference between users and
nonusers of TCAM in terms of disease characteristics [e.g.
[23,37]]. Other studies have, however, shown significant
correlations between lower CD4 cell count [45] and time
since diagnosis [39,46].
Study limitations
The study findings may not be generalizable to HIV treat-
ment naïve patients of public health facilities outside the
Uthukela health district in KwaZulu-Natal, South Africa,
to HIV patients below 18 years of age, and to HIV treat-
ment naïve patients who did not access public health serv-
ices. The sample in this study included 29.1% male and
70.9% female HIV-positive patients. Results found equal
herb use between the sexes and significantly more TCAM
use among female than male HIV-positive patients. This
may indicate a selection bias towards female HIV-positive
patients. However, other studies in South and Southern
Africa have shown similar female to male ratios. From a
random sample of 1072 adult pre-ART and ART patients
across three different sites (public urban hospital, peri-
urban non-governmental organisation (NGO) clinic site,
and a rural NGO clinic) in Gauteng Province, South
Africa, 21% were male and 79% female [44]. Muula et al.
[47] found that in most Southern African countries, pro-
portionally more females are on HIV antiretroviral treat-
ment than men, even when the higher HIV infection
prevalence in females is accounted for; the majority of the
reports had female: male ratio in treatment exceeding 1.6.
Further, this study was using hospital patients, therefore
the study results cannot be generalized to the general
popluation of persons with living with HIV/AIDS in the
study area/South Africa. The cross-sectional study design
did not permit an investigation of the cause-effect rela-
tionship between HIV/AIDS and use of herbs and TCAM.
Recall bias of study participants cannot be excluded. Par-
ticipants were often discouraged by health care providers
to use traditional medicines and although participants
were interviewed by external research assistants they may
not have revealed the real extent of TCAM use.
Conclusion
Traditional herbal therapies and TCAM are commonly
used by HIV treatment naïve outpatients of public health
facilities in South Africa. In some cases TCAM use may
have interactions causing a decrease in ART effectiveness
or even toxicity. It is not surprising therefore that the
South African ART guidelines do not encourage the con-
comitant use of ARV and traditional medicine. Further
pharmacokinetic and pharmacodynamic studies are
needed to identify the potential risks, benefits, and inter-
actions or non-interactions associated with concomitant
ARV drug and herbal medicines, and the effects of TCAM
use amongst patients on ART. Health care providers
should routinely screen patients on TCAM use when initi-
ating ART and also during follow-up and monitoring,
keeping in mind that these patients may not fully disclose
other therapies. Clinicians should endeavor to rule out
ART interactions with TCAM that may result in therapeu-
tic failure, side effects, toxicity and perhaps non-adher-
ence. A more holistic approach to patient health care, with
greater acceptance and acknowledgement that patients
may use other sources of treatment will help patients to
build trust with their HIV physician or nurse. An open dia-
logue between health care provider and patient about the
importance of religious and spiritual practices in their
lives should also be taken into account. Although there is
a certain degree of co-operation between the government
and faith-based organizations, results from this study
highlight the need for further engagement between the
two. Mapping both tangible and intangible religious
health assets has proved useful in neighbouring countries
in allowing gaps to be filled, resources to be channeled
appropriately and interventions to be be designed [48].
An assets-based approach would therefore be of benefit in
identifying, supporting and mobilizing religious health
assets in this area. Patients should be involved more in the
treatment decision-making process and provided with
information on which aspects of TCAM can be safely
incorporated into their medical regimen. Co-location of
services including voluntary organizations offering spirit-
ual and/or holistic health care advice may help to address
patients' needs where health care providers lack the time
or knowledge to adequately address these issues.
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